Search - tctmd.com

Displaying 281 - 300 of 344

Sort: Relevancy | Date

News Conference News ACC 2014

EUROMAX: Bivalirudin May Hold Key to Solving Problem of Early ST After Primary PCI

Jason Kahn

March 29, 2014

News Daily News

Mortality Benefit with ACE Inhibitors in Nonobstructive CAD

L.A. McKeown

March 20, 2014

News Daily News

HORIZONS-AMI: Kidney Damage During Primary PCI Closely Tied to Prognosis

March 20, 2014

News Daily News

HORIZONS-AMI: El Daño Renal Durante una PCI Primaria está Estrechamente asociado al Pronóstico

March 20, 2014

News Daily News

Most Nonculprit Lesions with Plaque Rupture Do not Lead to Increased Events

March 13, 2014

News Daily News

DEFER-STEMI Published: Delayed Stenting Improves Outcomes in Higher-Risk STEMI Patients

March 05, 2014

News Daily News

La Implantación Diferida de Stents Mejora los Resultados en Pacientes STEMI de Mayor Riesgo

March 05, 2014

News Daily News

Ticagrelor Loading Dose May be Unnecessary for ACS Patients Previously on Clopidogrel

Caitlin E. Cox

January 29, 2014

News Daily News

Studies Explore How, When Radial PCI Benefits ACS/STEMI Patients

January 01, 2014

Presentation TCT 2013

Guideline Strategies for Antithrombotic Therapy in ACS: Contrasting the European and US Perspectives

Presenter: Philippe Gabriel Steg

October 30, 2013

News Daily News

Los Subgrupos de Alto Riesgo obtienen Protección Renal de la Rosuvastatina

Caitlin E. Cox

October 11, 2013

News Daily News

High-Risk Subgroups Derive Kidney Protection from Rosuvastatin

Caitlin E. Cox

October 11, 2013

Presentation

PRATO-ACS: Early High-Dose Rosuvastatin for Contrast-Induced Nephropathy Prevention in ACS

Presenter: M. Leoncini

October 09, 2013

News Daily News

Baseline White Blood Cell Count Predicts Infarct Size in Anterior STEMI

Yael L. Maxwell

September 27, 2013

News Conference News ESC 2013

PRAMI: Strong Showing for Complete Revascularization in Acute STEMI Patients

Caitlin E. Cox

September 01, 2013

News Daily News

HORIZONS-AMI: Bivalirudin, Taxus Improve Outcomes in LAD PCI Patients

Leah Lawrence

July 11, 2013

News Daily News

REOPEN-AMI Published: Adenosine Reduces ‘No-Reflow’ in STEMI Patients

July 05, 2013

News Daily News

STEMI Marked by Microvascular Dysfunction Linked to Higher Long-term Mortality

Jason Kahn

June 28, 2013

News Daily News

STEMI marcado por disfunción microvascular vinculado a mayor mortalidad a largo plazo

Jason Kahn

June 28, 2013

News Daily News

Prasugrel Noninferior to Ticagrelor in STEMI, but Both Require Hours to Achieve Effect

Yael L. Maxwell

May 13, 2013

Advertisement

EUROMAX: Bivalirudin May Hold Key to Solving Problem of Early ST After Primary PCI

Mortality Benefit with ACE Inhibitors in Nonobstructive CAD

HORIZONS-AMI: Kidney Damage During Primary PCI Closely Tied to Prognosis

HORIZONS-AMI: El Daño Renal Durante una PCI Primaria está Estrechamente asociado al Pronóstico

Most Nonculprit Lesions with Plaque Rupture Do not Lead to Increased Events

DEFER-STEMI Published: Delayed Stenting Improves Outcomes in Higher-Risk STEMI Patients

La Implantación Diferida de Stents Mejora los Resultados en Pacientes STEMI de Mayor Riesgo

Ticagrelor Loading Dose May be Unnecessary for ACS Patients Previously on Clopidogrel

Studies Explore How, When Radial PCI Benefits ACS/STEMI Patients

Guideline Strategies for Antithrombotic Therapy in ACS: Contrasting the European and US Perspectives

Los Subgrupos de Alto Riesgo obtienen Protección Renal de la Rosuvastatina

High-Risk Subgroups Derive Kidney Protection from Rosuvastatin

PRATO-ACS: Early High-Dose Rosuvastatin for Contrast-Induced Nephropathy Prevention in ACS

Baseline White Blood Cell Count Predicts Infarct Size in Anterior STEMI

PRAMI: Strong Showing for Complete Revascularization in Acute STEMI Patients

HORIZONS-AMI: Bivalirudin, Taxus Improve Outcomes in LAD PCI Patients

REOPEN-AMI Published: Adenosine Reduces ‘No-Reflow’ in STEMI Patients

STEMI Marked by Microvascular Dysfunction Linked to Higher Long-term Mortality

STEMI marcado por disfunción microvascular vinculado a mayor mortalidad a largo plazo

Prasugrel Noninferior to Ticagrelor in STEMI, but Both Require Hours to Achieve Effect

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content